Level Biotechnology Total Liabilities

Latest as of September 2025: NT$237.03 Million TWD ≈ $7.47 Million USD

Level Biotechnology total liabilities. Based on the latest financial reports, Level Biotechnology (3118) has total liabilities worth NT$237.03 Million TWD (≈ $7.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Level Biotechnology to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Level Biotechnology (2017–2024)

Total liabilities of Level Biotechnology from 2017 to 2024. This chart illustrates how Level Biotechnology's total liabilities have evolved over time, based on quarterly financial data.

Level Biotechnology Competitors by Total Liabilities

The table below lists competitors of Level Biotechnology ranked by their total liabilities.

Company	Country	Total Liabilities
Chiu Ting Machinery Co Ltd TW:1539	Taiwan	NT$636.03 Million
Sun Race Sturmey-Archer Inc TW:1526	Taiwan	NT$960.72 Million
Luks Kadife Ticaret ve Sanayi AS IS:LUKSK	Turkey	TL466.86 Million
Medical Developments International Ltd AU:MVP	Australia	AU$11.29 Million
Argosy Minerals Ltd AU:AGY	Australia	AU$530.28K
Ant Precision Industry Co Ltd TWO:3646	Taiwan	NT$397.76 Million
Gencurix Inc KQ:229000	Korea	₩18.57 Billion
TINYBUILD REGSCAT3 DL-001 F:8Z3	Germany	€11.50 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Level Biotechnology's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Level Biotechnology.

Liquidity & Leverage Metrics

Level Biotechnology Total Liabilities Ratios Explained

Level Biotechnology total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Level Biotechnology's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Level Biotechnology (2017–2024)

The table below shows the annual total liabilities of Level Biotechnology from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$267.19 Million ≈ $8.42 Million	-2.20%
2023-12-31	NT$273.20 Million ≈ $8.61 Million	+1.14%
2022-12-31	NT$270.13 Million ≈ $8.51 Million	+11.27%
2021-12-31	NT$242.78 Million ≈ $7.65 Million	-0.32%
2020-12-31	NT$243.56 Million ≈ $7.67 Million	+3.01%
2019-12-31	NT$236.43 Million ≈ $7.45 Million	+30.19%
2018-12-31	NT$181.60 Million ≈ $5.72 Million	-13.53%
2017-12-31	NT$210.03 Million ≈ $6.62 Million	--

About Level Biotechnology

TWO:3118 Taiwan Biotechnology

Market Cap

$31.08 Million

NT$986.57 Million TWD

Market Cap Rank

#23453 Global

#1475 in Taiwan

Share Price

NT$30.40

Change (1 day)

-0.65%

52-Week Range

NT$30.40 - NT$34.10

All Time High

NT$37.15